|
[1]Kononen J, Bubendorf L, Kallioniemi A. Tissue microarrays for high throughout molecular profiling of tumor specimens[J]. Nature Med, 1998, 4∶844-47.
|
|
[2]Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma[J]. World J Gastroenterol, 2002, 8 (3) ∶385-92.
|
|
[3]Pizem J, Marolt VF, Luzar B, et al. Proliferative and apoptoctic activity in hepatocellular carcinoma and surrouding non-neoplastic liver tissue[J]. Pflugers Arch, 2001, 442 (6 Suppl 1) ∶R174-6.
|
|
[4]Lu S, Tiekso J, Hietanen S, et al. Expression of cell-cycle proteins p53, p21 (WAF-1) , PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement[J]. Acta Derm Venereol, 1999, 79 (4) ∶268-73.
|
|
[5]Koga H, Sakisaka S, Harada M, et al. Involvement of p21 (WAF1/CIP1) , p27 (Kip1) , and p18 (INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines[J]. Hepatology, 2001, 33 (5) ∶1087-97.
|
|
[6]Qin LF, NgIO. Expression of p27 (KIP1) and p21 (WAF1/CIP1) in primary hepatocellular carcinoma:clinicopathologic correlation and survival analysis[J].Hum Pathol, 2001, 32 (8) ∶778-84.
|